MENU

Pfizer’s stock down 8% as 2024 profit and revenue guidance falls short of expectations

Drugmaker expands cost-cutting program as it wraps up Seagen acquisition.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story